Results 151 to 160 of about 392,357 (290)
Correlation Joins over Time Series Data Streams Utilizing Complementary Dimension Reduction and Transformation [PDF]
AmirReza Alizade Nikoo +2 more
openalex +1 more source
ABSTRACT Objective To investigate the value of constructing models based on habitat radiomics and pathomics for predicting the risk of progression in high‐grade gliomas. Methods This study conducted a retrospective analysis of preoperative magnetic resonance (MR) images and pathological sections from 72 patients diagnosed with high‐grade gliomas (52 ...
Yuchen Zhu +14 more
wiley +1 more source
Dimensionality reduction of genetic data using contrastive learning. [PDF]
Thor F, Nettelblad C.
europepmc +1 more source
Power Reduction of Multi-Carrier Transmission System by Using Multi-Dimensional Constellation Mappings [PDF]
Kyoungwon Lee +2 more
openalex +1 more source
ABSTRACT Objective Glioma recurrence severely impacts patient prognosis, with current treatments showing limited efficacy. Traditional methods struggle to analyze recurrence mechanisms due to challenges in assessing tumor heterogeneity, spatial dynamics, and gene networks.
Lei Qiu +10 more
wiley +1 more source
An empirical evaluation of dimensionality reduction and class balancing for medical text classification. [PDF]
Jamil A, Hanif MK, Sarwar MU, Khan MI.
europepmc +1 more source
Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito +14 more
wiley +1 more source
Neural Active Manifolds: Nonlinear Dimensionality Reduction for Uncertainty Quantification. [PDF]
Zanoni A +4 more
europepmc +1 more source
Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher +10 more
wiley +1 more source

